iDose TR® (travoprost intracameral implant)
for Glaucoma

iDose TR (travoprost) is a long-acting eye implant used to lower intraocular pressure (IOP) in adults with open-angle glaucoma (OAG) or ocular hypertension (OHT). It works by slowly releasing travoprost, a prostaglandin analog that increases fluid drainage from the eye, reducing pressure. By lowering IOP, iDose TR helps decrease the risk of vision loss in OHT and slows the progression of vision loss in OAG.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Glaucoma